pharma · Fibromyalgia · Primary Fibromyalgia · TNXP
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 200 Connell Dr, Berkeley Heights, New Jersey 07922, US
- Founded
- 2007
- Employees
- 154
- Programs
- 30
- Drugs
- 10
- Patents
- 86
Tonix Pharmaceuticals Holding projects
7 ClinicalTrials.gov programs sponsored by Tonix Pharmaceuticals Holding.
Tonix Pharmaceuticals Holding has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Cyclobenzaprine HCl
Tonix Pharmaceuticals Holding
Acute Stress Reaction
1 trial -
TNX-102 SL
Tonix Pharmaceuticals Holding
Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection
1 trial -
TNX-1300
Tonix Pharmaceuticals Holding
Cocaine Intoxication
1 trial -
TNX-1500
Tonix Pharmaceuticals Holding
Kidney Transplant
1 trial -
TNX-1900
Tonix Pharmaceuticals Holding
Chronic Migraine
1 trial -
TNX-201
Tonix Pharmaceuticals Holding
Tension-Type Headache
1 trial -
TNX-601 ER
Tonix Pharmaceuticals Holding
Depression
1 trial
Frequently asked questions
How many clinical projects does Tonix Pharmaceuticals Holding have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.